{
    "clinical_study": {
        "@rank": "127684", 
        "arm_group": [
            {
                "arm_group_label": "WC3036-11F", 
                "arm_group_type": "Active Comparator", 
                "description": "Treatment A"
            }, 
            {
                "arm_group_label": "WC3036-12F", 
                "arm_group_type": "Experimental", 
                "description": "Treatment B"
            }, 
            {
                "arm_group_label": "WC3036-13P", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Treatment C"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to assess the safety & efficacy of a single dose of alprostadil\n      cream with 2 concentrations of WC3036 compared to vehicle alone in men with erectile\n      dysfunction."
        }, 
        "brief_title": "Efficacy & Safety of Single Dose Alprostadil Cream (2 Concentrations Enhancer) to Vehicle in Men w/Erectile Dysfunction", 
        "completion_date": {
            "#text": "April 2013", 
            "@type": "Actual"
        }, 
        "condition": "Erectile Dysfunction", 
        "condition_browse": {
            "mesh_term": "Erectile Dysfunction"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Male subject aged 40 or older of any race\n\n          -  History of ED (erectile dysfunction) of at least 3 months duration defined as\n             inability to attain & maintain an erection of the penis sufficient to permit\n             satisfactory sexual intercourse\n\n          -  Completed and signed informed consent prior to any study related procedures\n\n        Exclusion Criteria:\n\n          -  History/presence any significant disease that Investigator feels will interfere with\n             course of the study\n\n          -  Anatomic deformity of penis\n\n          -  History/presence alcoholism or drug abuse/dependence within past 2 years (discretion\n             of Investigator)\n\n          -  Participation in investigational study drug trial within 30 days prior to\n             randomization"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "40 Years"
        }, 
        "enrollment": {
            "#text": "16", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "February 27, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01810575", 
            "org_study_id": "PR-13311"
        }, 
        "intervention": [
            {
                "arm_group_label": "WC3036-11F", 
                "description": "330 mcg alprostadil per 100 mg cream; WC3036 at a concentration of 2.5% w/w", 
                "intervention_name": "WC3036-11F", 
                "intervention_type": "Drug", 
                "other_name": "Treatment A"
            }, 
            {
                "arm_group_label": "WC3036-12F", 
                "description": "330 mcg alprostadil per 100 mg cream; WC3036 at a concentration of 0.5% w/w", 
                "intervention_name": "WC3036-12F", 
                "intervention_type": "Drug", 
                "other_name": "Treatment B"
            }, 
            {
                "arm_group_label": "WC3036-13P", 
                "description": "100 mg cream; WC3036 at a concentration of 0.5% w/w.", 
                "intervention_name": "WC3036-13P", 
                "intervention_type": "Drug", 
                "other_name": "Treatment C"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Alprostadil"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "August 5, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Purchase", 
                    "country": "United States", 
                    "state": "New York", 
                    "zip": "10755"
                }, 
                "name": "Warner Chilcott Investigational Study Site"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "3", 
        "official_title": "A Study to Assess the Relative Efficacy and Safety of a Single Dose of Alprostadil Cream Combined With 2 Concentrations of WC3036 Compared to Vehicle in Subjects With Erectile Dysfunction", 
        "overall_official": {
            "affiliation": "Warner Chilcott", 
            "last_name": "Vilma Sniukiene, MD", 
            "role": "Study Director"
        }, 
        "overall_status": "Terminated", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "April 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "description": "\u226560% at base and tip of penis lasting for \u2265 5 minutes evaluated with RigiScan. Treatment visits will be separated by at least 2 days.", 
                "measure": "Penile rigidity", 
                "safety_issue": "No", 
                "time_frame": "Visit 1 / Up to 5 days \u00b1 3 days"
            }, 
            {
                "description": "\u226560% at base and tip of penis lasting for \u2265 5 minutes evaluated with RigiScan.  Treatment visits will be separated by at least 2 days.", 
                "measure": "Penile rigidity", 
                "safety_issue": "No", 
                "time_frame": "Visit 2 / Up to 9 days \u00b1 3 days"
            }, 
            {
                "description": "\u226560% at base and tip of penis lasting for \u2265 5 minutes evaluated with RigiScan. Treatment visits will be separated by at least 2 days.", 
                "measure": "Penile rigidity", 
                "safety_issue": "No", 
                "time_frame": "Visit 3 / Up to 14 Days"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01810575"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Subject description of quality of erection using non-validated questionnaire.  Treatment visits will be separated by at least 2 days.", 
                "measure": "Quality of erection", 
                "safety_issue": "No", 
                "time_frame": "Visit 1 / Up to 5 days \u00b1 3 days"
            }, 
            {
                "description": "Subject description of quality of erection using non-validated questionnaire.  Treatment visits will be separated by at least 2 days.", 
                "measure": "Quality of erection", 
                "safety_issue": "No", 
                "time_frame": "Visit 2 / Up to 9 days \u00b1 3 days"
            }, 
            {
                "description": "Subject description of quality of erection using non-validated questionnaire.  Treatment visits will be separated by at least 2 days.", 
                "measure": "Quality of erection", 
                "safety_issue": "No", 
                "time_frame": "Visit 3 / Up to 14 days"
            }
        ], 
        "source": "Warner Chilcott", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Warner Chilcott", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "February 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "August 2013", 
        "why_stopped": "Re-assessment of study"
    }
}